You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 5, May 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  REGULAR DEPARTMENTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CHICAGO DERMATOLOGICAL SOCIETY

David F. Fretzin, MD

Arch Dermatol. 1977;113(5):692-695.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Halotex (haloprogin) 1% Cream/Solution Caution: Federal law prohibits dispensing without prescription. Description:Halotex cream provides 1% haloprogin in a water-dispersible, semi-solid cream base. Each gram contains 10 mg. haloprogin solubilized in polyethylene glycol 400, polyethylene glycol 4000, diethyl sebacate and polyvinylpyrrolidone. Halotex solution provides 1% (10 mg. per ml.) haloprogin in a homogeneous vehicle of diethyl sebacate and alcohol. Action: Halotex is a synthetic antifungal agent for the treatment of superficial fungal infections of the skin. Indications: Halotex cream and solution are indicated for the topical treatment of tinea pedis, tinea cruris, tinea corporis and tinea manuum due to infection with Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Microsporum canis, and Epidermophyton floccosum. It is also useful in the topical treatment of tinea versicolor due to Malassezia furfur. Contraindications: Halotex preparations are contraindicated in those individuals who have shown hypersensitivity to any of the components. Warning: USAGE IN PREGNANCY—Safety for use in . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.